Replies to post #50897 on Biotech Values

[DewDiligence]

HCV: Most Likely to Succeed

>Just wondering if you have a list of the Hep C programs considered most likely to succeed?<

In descending order of likelihood of success (IMO):

1. Telaprevir (VRTX/JNJ in phase-2).

2. The various enhanced interferons: Albuferon (NVS/HGSI in phase-3), Locteron (OctoPlus/Biolex in preclinical), and Maxy-Alpha (Roche/MAXY in preclinical).

3. The protease inhibitors from Roche/ITMN and SGP.

4. Various early-stage compounds from GILD (alone), GILD/ACHN, Roche/VRUS, and IDIX.

JMHO, FWIW